An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine

For studies of the behavioral and physiological effects of nicotine in smokers, delivery of nicotine via cigarette smoking is highly variable and difficult to control. A more precise method of delivery is needed in order to accurately manipulate the amount of nicotine being presented and, thus, to determine its quantitative effects. The objective of the study reported here was to test an aerosol nasal-spray method of delivering measured doses of nicotine. Eleven healthy males were presented 0 mg (placebo), 0.5 mg, 1.0 mg, and 2.0 mg of nicotine over 5 min during four separate sessions, and changes were observed in plasma nicotine concentration and cardiovascular activity. Dose-response relationships were observed between nicotine presented via this method and plasma nicotine, heart rate, systolic blood pressure, and, to a lesser extent, diastolic blood pressure. These results suggest that this aerosol spray method of presenting nicotine provides the measured doses necessary for quantification of nicotine’s effects.

[1]  L. Epstein,et al.  The effect of smoking on perception of muscle tension , 2004, Psychopharmacology.

[2]  J. Rose,et al.  Sensory blockade of smoking satisfaction , 1985, Pharmacology Biochemistry and Behavior.

[3]  R. Herning,et al.  How a cigarette is smoked determines blood nicotine levels , 1983, Clinical pharmacology and therapeutics.

[4]  R T Jones,et al.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. , 1982, The Journal of pharmacology and experimental therapeutics.

[5]  M. Jarvis,et al.  Nicotine intake by snuff users. , 1981, British medical journal.

[6]  C. Feyerabend,et al.  EFFECT OF URINARY pH AND NICOTINE EXCRETION RATE ON PLASMA NICOTINE DURING CIGARETTE SMOKING AND CHEWING NICOTINE GUM , 1978 .

[7]  L. Epstein,et al.  Measurement of smoking topography during withdrawal or deprivation , 1981 .

[8]  M. Aceto,et al.  Central actions of nicotine , 1982, Medicinal research reviews.

[9]  K. Bättig,et al.  Cardiovascular effects of smoking cigarettes with different nicotine deliveries , 1983, Psychopharmacology.

[10]  J. Henningfield,et al.  Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  N. Hengen,et al.  Gas-liquid chromatographic determination of nicotine and cotinine in plasma. , 1978, Clinical chemistry.

[12]  A. Horsch,et al.  Evaluation of smoking-induced effects on sympathetic, hemodynamic and metabolic variables with respect to plasma nicotine and COHb levels. , 1979, Atherosclerosis.

[13]  Recording puff volume in smoking , 1983 .

[14]  C. Dollery,et al.  Absorption and metabolism of nicotine from cigarettes. , 1975, British medical journal.

[15]  P. Cryer,et al.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. , 1976, The New England journal of medicine.

[16]  C. Feyerabend,et al.  Nicotine pharmacokinetics and its application to intake from smoking. , 1985, British journal of clinical pharmacology.

[17]  J. Jaffe,et al.  Smoking as an addictive disorder. , 1979, NIDA research monograph.

[18]  M. Jarvik,et al.  Cigarette smoking during anxiety-provoking and monotonous tasks. , 1983, Addictive behaviors.

[19]  G. Mangan,et al.  The Psychopharmacology of Smoking , 1984 .

[20]  T. Gayle,et al.  An instrumental cigarette smoke monitor designed for the direct measurement of smoke particulate matter generated in human smoking studies , 1984 .

[21]  O. Pomerleau,et al.  The effects of cigarette smoking on pain and anxiety. , 1984, Addictive behaviors.

[22]  M. F. Dube,et al.  Methods of collection of smoke for analytical purposes , 1982 .

[23]  N. Benowitz,et al.  Disposition kinetics and effects of intravenous nicotine , 1980, Clinical pharmacology and therapeutics.

[24]  C. Feyerabend,et al.  Cigarette smoking: a dependence on high-nicotine boli. , 1978, Drug metabolism reviews.

[25]  A. Horsch,et al.  Acute cardiovascular reactions after cigarette smoking. , 1980, Atherosclerosis.

[26]  K. Wesnes,et al.  Smoking, nicotine and human performance. , 1983, Pharmacology & therapeutics.

[27]  K. Bättig,et al.  Psychophysiological correlates of conflict solving and cigarette smoking. , 1983, Activitas nervosa superior.

[28]  R. Ebert,et al.  Plasma nicotine levels produced by chewing nicotine gum. , 1982, JAMA.

[29]  S. Gust,et al.  Does cigarette nicotine yield affect puff volume? , 1982, Clinical pharmacology and therapy.